This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parsons, L. M.
Right arrow Articles by Taber, H. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parsons, L. M.
Right arrow Articles by Taber, H. W.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2005, p. 2218-2225, Vol. 49, No. 6
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.6.2218-2225.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Phenotypic and Molecular Characterization of Mycobacterium tuberculosis Isolates Resistant to both Isoniazid and Ethambutol

Linda M. Parsons,1,2,{dagger} Max Salfinger,1,2,3* Anne Clobridge,1 Jillian Dormandy,1 Lisa Mirabello,2 Valerie L. Polletta,1 Ahmet Sanic,1,{ddagger} Oleg Sinyavskiy,1 Susan C. Larsen,1 Jeffrey Driscoll,1 Genet Zickas,1 and Harry W. Taber1,2

Wadsworth Center, New York State Department of Health,1 Department of Biomedical Sciences, School of Public Health, University at Albany,2 Department of Medicine, Albany Medical College, Albany, New York3

Received 12 October 2004/ Returned for modification 29 November 2004/ Accepted 23 February 2005

In performing radiometric susceptibility testing on over 2,000 patient isolates of Mycobacterium tuberculosis during the past 6 years, we found that resistance to 7.5 µg/ml ethambutol (EMB) occurred only in isolates that are also resistant to 0.4 µg/ml isoniazid (INH). Using 157 selected isolates in the present study, we performed radiometric and agar proportion susceptibility tests and DNA sequencing of genetic regions associated with resistance to these two drugs. The goal was to study the occurrence of the common mutations associated with resistance to each drug and also to determine whether any particular INH-resistance-associated mutation occurred more often in combination with any particular EMB-resistance-associated mutation. In an analysis of 128 isolates resistant to 0.4 µg/ml INH, we found that a mutation at katG Ser315 was more common in isolates also resistant to 7.5 µg/ml EMB (61 of 67 = 91.0%) than in isolates either susceptible to EMB or resistant to 2.5 µg/ml EMB (39 of 60 = 65.0%). These observations suggest that INH-resistant strains with a mutation at katG Ser315 are more likely to acquire resistance to 7.5 µg/ml EMB than are isolates with INH-resistance-associated mutations at other sites. In addition, we found that 64 of 67 (95.5%) isolates resistant to 7.5 µg/ml EMB contained a mutation in either codon 306 or codon 406 of embB. Met306Val was the most common embB mutation, present in 52 (77.6%) of the 67 isolates. Most occurrences of this mutation (49 of 52 = 94.2%) were found in isolates that also contained the katG Ser315Thr mutation. Finally, sequencing this region of embB appears to be sufficiently sensitive for use as a rapid screening tool for detection of high-level resistance to EMB.

* Corresponding author. Mailing address: 120 New Scotland Ave., Albany, NY 12208. Phone: (518) 474-2196. Fax: (518) 474-6964. E-mail: salfinger{at}wadsworth.org.

{dagger} Present address: Global AIDS Program, Centers for Disease Control and Prevention, Atlanta, GA.

{ddagger} Present address: Ondokuz Mayis University, Samsun, Turkey.

Antimicrobial Agents and Chemotherapy, June 2005, p. 2218-2225, Vol. 49, No. 6
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.6.2218-2225.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Suarez, J., Ranguelova, K., Schelvis, J. P. M., Magliozzo, R. S. (2009). Antibiotic Resistance in Mycobacterium tuberculosis: PEROXIDASE INTERMEDIATE BYPASS CAUSES POOR ISONIAZID ACTIVATION BY THE S315G MUTANT OF M. TUBERCULOSIS CATALASE-PEROXIDASE (KatG). J. Biol. Chem. 284: 16146-16155 [Abstract] [Full Text]  
  • Hillemann, D., Rusch-Gerdes, S., Richter, E. (2009). Feasibility of the GenoType MTBDRsl Assay for Fluoroquinolone, Amikacin-Capreomycin, and Ethambutol Resistance Testing of Mycobacterium tuberculosis Strains and Clinical Specimens. J. Clin. Microbiol. 47: 1767-1772 [Abstract] [Full Text]  
  • Starks, A. M., Gumusboga, A., Plikaytis, B. B., Shinnick, T. M., Posey, J. E. (2009). Mutations at embB Codon 306 Are an Important Molecular Indicator of Ethambutol Resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 53: 1061-1066 [Abstract] [Full Text]  
  • Safi, H., Sayers, B., Hazbon, M. H., Alland, D. (2008). Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, and Rifampin. Antimicrob. Agents Chemother. 52: 2027-2034 [Abstract] [Full Text]  
  • Romero, B., Aranaz, A., Bezos, J., Alvarez, J., de Juan, L., Mateos, A., Gomez-Mampaso, E., Dominguez, L. (2008). Single-Nucleotide Polymorphism in Two Representative Multidrug-Resistant Mycobacterium bovis Isolates Collected from Patients in a Spanish Hospital Harboring a Human Infection Outbreak. J. Clin. Microbiol. 46: 826-827 [Full Text]  
  • Gumbo, T., Louie, A., Liu, W., Brown, D., Ambrose, P. G., Bhavnani, S. M., Drusano, G. L. (2007). Isoniazid Bactericidal Activity and Resistance Emergence: Integrating Pharmacodynamics and Pharmacogenomics To Predict Efficacy in Different Ethnic Populations. Antimicrob. Agents Chemother. 51: 2329-2336 [Abstract] [Full Text]  
  • Dormandy, J., Somoskovi, A., Kreiswirth, B. N., Driscoll, J. R., Ashkin, D., Salfinger, M. (2007). Discrepant Results Between Pyrazinamide Susceptibility Testing by the Reference BACTEC 460TB Method and pncA DNA Sequencing in Patients Infected With Multidrug-Resistant W-Beijing Mycobacterium tuberculosis Strains. Chest 131: 497-501 [Abstract] [Full Text]  
  • Somoskovi, A., Dormandy, J., Mitsani, D., Rivenburg, J., Salfinger, M. (2006). Use of Smear-Positive Samples To Assess the PCR-Based Genotype MTBDR Assay for Rapid, Direct Detection of the Mycobacterium tuberculosis Complex as Well as Its Resistance to Isoniazid and Rifampin. J. Clin. Microbiol. 44: 4459-4463 [Abstract] [Full Text]  
  • Hazbon, M. H., Brimacombe, M., Bobadilla del Valle, M., Cavatore, M., Guerrero, M. I., Varma-Basil, M., Billman-Jacobe, H., Lavender, C., Fyfe, J., Garcia-Garcia, L., Leon, C. I., Bose, M., Chaves, F., Murray, M., Eisenach, K. D., Sifuentes-Osornio, J., Cave, M. D., Ponce de Leon, A., Alland, D. (2006). Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosis.. Antimicrob. Agents Chemother. 50: 2640-2649 [Abstract] [Full Text]  
  • Plinke, C., Rusch-Gerdes, S., Niemann, S. (2006). Significance of Mutations in embB Codon 306 for Prediction of Ethambutol Resistance in Clinical Mycobacterium tuberculosis Isolates.. Antimicrob. Agents Chemother. 50: 1900-1902 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»